EUR 150,000 University grant for ALS-related research to Merja Voutilainen
Dr. Merja Voutilainen from the Institute of Biotechnology has been granted a three-year research grant by the University of Helsinki. Merja Voutilainen’s research team studies CDNF/MANF family of neurotrophic factors in neurodegenerative diseases and their relation to endoplasmic reticulum stress.

The University of Helsinki three-year research grant of EUR 150,000 has been awarded to Dr.  Merja Voutilainen to study the role of Cerebral Dopamine Neurotrophic Factor, CDNF, in amyotrophic lateral sclerosis (ALS).

Dr. Voutilainen's team is trying to find neurorestorative treatments for ALS that slow down or stop the disease progression. Currently, there are no drugs or disease modifying treatments for ALS.